Children aged 0-15 years lag behind adults in achieving HIV treatment goals across HIV testing, initiation of antiretroviral therapy and viral suppression. While early diagnosis of pediatric HIV has scaled up significantly, children continue to slip through the cracks and remain undiagnosed and untreated. For children living with HIV, challenges in adherence to treatment is hampered by family and caregiving structures leaving children prone to poor viral suppression. Recent advances in treatment including newer dolutegravir based regimens and easy to use treatment formulations have improved adherence and viral suppression in children but gaps remain in achieving optimal viral suppression. This talk will focus on the state of the HIV care continuum for children aged 0-15 years, focusing on current trends, gaps and advances to improve the cascade of care in children.
CROI Conference
